3,069 Shares in Henry Schein, Inc. (NASDAQ:HSIC) Acquired by Cypress Capital Group

Cypress Capital Group bought a new stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 3,069 shares of the company’s stock, valued at approximately $224,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Gabelli Funds LLC boosted its position in shares of Henry Schein by 0.4% during the first quarter. Gabelli Funds LLC now owns 364,636 shares of the company’s stock valued at $27,537,000 after purchasing an additional 1,600 shares in the last quarter. Magnetar Financial LLC grew its position in shares of Henry Schein by 229.9% in the 1st quarter. Magnetar Financial LLC now owns 386,458 shares of the company’s stock worth $29,185,000 after buying an additional 269,330 shares during the period. California State Teachers Retirement System increased its stake in shares of Henry Schein by 1.7% in the 1st quarter. California State Teachers Retirement System now owns 212,108 shares of the company’s stock worth $16,018,000 after acquiring an additional 3,534 shares in the last quarter. Tidal Investments LLC lifted its position in Henry Schein by 21.4% during the 1st quarter. Tidal Investments LLC now owns 5,632 shares of the company’s stock valued at $425,000 after acquiring an additional 994 shares during the period. Finally, Wahed Invest LLC boosted its stake in Henry Schein by 14.3% during the first quarter. Wahed Invest LLC now owns 2,540 shares of the company’s stock worth $192,000 after acquiring an additional 318 shares in the last quarter. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Henry Schein Price Performance

Shares of HSIC stock opened at $73.91 on Friday. The company has a market capitalization of $9.21 billion, a P/E ratio of 30.41, a P/E/G ratio of 2.15 and a beta of 0.87. The company’s 50-day simple moving average is $70.68 and its two-hundred day simple moving average is $69.69. Henry Schein, Inc. has a one year low of $63.67 and a one year high of $82.63. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. During the same period last year, the business posted $1.32 EPS. Henry Schein’s quarterly revenue was up .4% on a year-over-year basis. As a group, equities analysts anticipate that Henry Schein, Inc. will post 4.78 EPS for the current year.

Analysts Set New Price Targets

HSIC has been the subject of several recent research reports. JPMorgan Chase & Co. lowered their target price on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a report on Monday, August 12th. UBS Group lowered their price objective on Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. Barrington Research reissued an “outperform” rating and issued a $82.00 target price on shares of Henry Schein in a research note on Wednesday, November 6th. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Finally, Evercore ISI increased their price objective on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research report on Tuesday, October 8th. Six investment analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, Henry Schein has a consensus rating of “Moderate Buy” and a consensus target price of $78.89.

Insider Buying and Selling

In other news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the sale, the chief operating officer now owns 87,706 shares in the company, valued at approximately $6,577,950. This represents a 12.25 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the sale, the senior vice president now owns 71,833 shares in the company, valued at $4,978,026.90. The trade was a 22.65 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.